InMed Pharmaceuticals Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Vancouver, British Columbia, Canada
SEC filing record 1 source field available
Fiscal year end
30 June
InMed Pharmaceuticals Inc. has filed 492 SEC EDGAR filings since 17 Jan 2018

SEC filing history

Showing 351-375 of 492 matching filings.

Per page
25
Current page
15
4

4 filing

Filing date
24 Jan 2022
Reporting date
24 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
24 Jan 2022
Reporting date
24 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
24 Jan 2022
Reporting date
24 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
24 Jan 2022
Reporting date
24 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39685

CURRENT REPORT

Filing date
19 Jan 2022
Reporting date
19 Jan 2022
Next action
Verify source filing
4

4 filing

Filing date
06 Jan 2022
Reporting date
06 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39685

CURRENT REPORT

Filing date
05 Jan 2022
Reporting date
05 Jan 2022
Next action
Verify source filing
4

4 filing

Filing date
30 Dec 2021
Reporting date
30 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
30 Dec 2021
Reporting date
29 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
30 Dec 2021
Reporting date
29 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
30 Dec 2021
Reporting date
29 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
30 Dec 2021
Reporting date
29 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 001-39685

AMENDMENT NO. 1 TO FORM 8-K

Filing date
22 Dec 2021
Reporting date
13 Oct 2021
Next action
Verify source filing
8-K File 001-39685

CURRENT REPORT

Filing date
20 Dec 2021
Reporting date
17 Dec 2021
Next action
Verify source filing
8-K File 001-39685

CURRENT REPORT

Filing date
23 Nov 2021
Reporting date
23 Nov 2021
Next action
Verify source filing
8-K/A File 001-39685

AMENDMENT NO. 1 TO FORM 8-K

Filing date
16 Nov 2021
Reporting date
10 Nov 2021
Next action
Verify source filing
4

4 filing

Filing date
15 Nov 2021
Reporting date
15 Nov 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39685

CURRENT REPORT

Filing date
10 Nov 2021
Reporting date
10 Nov 2021
Next action
Verify source filing
10-Q File 001-39685

QUARTERLY REPORT

Filing date
10 Nov 2021
Reporting date
30 Sep 2021
Next action
Verify source filing
3

3 filing

Filing date
09 Nov 2021
Reporting date
02 Nov 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39685

CURRENT REPORT

Filing date
03 Nov 2021
Reporting date
03 Nov 2021
Next action
Verify source filing
DEF 14A File 001-39685

PROXY STATEMENT

Filing date
28 Oct 2021
Reporting date
17 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-39685

DEFINITIVE ADDITIONAL MATERIALS

Filing date
28 Oct 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39685

CURRENT REPORT

Filing date
28 Oct 2021
Reporting date
27 Oct 2021
Next action
Verify source filing
D File 021-418909

D filing

Filing date
28 Oct 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .